MEK signaling represents a viable therapeutic vulnerability of KRAS-driven somatic brain arteriovenous malformations.
Suarez CF, Harb OA, Robledo A, Largoza G, Ahn JJ, Alley EK, Wu T, Veeraragavan S, McClugage ST, Iacobas I, Fish JE, Kan PT, Marrelli SP, Wythe JD.
Suarez CF, et al. Among authors: wu t.
bioRxiv [Preprint]. 2024 May 15:2024.05.15.594335. doi: 10.1101/2024.05.15.594335.
bioRxiv. 2024.
PMID: 38766159
Free PMC article.
Preprint.